NEW ORLEANS, LA—Adding the factor XIa inhibitor asundexian (Bayer) to antiplatelet therapy tops antiplatelet therapy alone for preventing ischemic strokes in patients with acute noncardioembolic ...
For many stroke survivors, recovery is derailed by painful muscle stiffness and involuntary spasms that limit movement, ...
Expanded eligibility for advanced ischemic stroke therapies and the first detailed recommendations pediatric stroke care are ...
The factor XIa inhibitor asundexian reduced recurrent ischemic stroke without increasing major or minor bleeding in patients ...
News Medical on MSN
Novel neuroprotective drug improves recovery after acute ischemic stroke
Stroke patients treated intravenously with loberamisal, a novel neuroprotective medication, daily for 10 days and starting ...
The American Heart Association/American Stroke Association released its 2026 Guideline for the Early Management of Patients With Acute Ischemic Stroke. Stroke published the guideline on Monday.
FOX 2 - Here's an alarming stat - when it comes to someone who has had a stroke, every minute that passes without the right ...
Among adults with acute non-cardioembolic ischemic stroke or high-risk transient ischemic attack (TIA) with planned ...
The American Heart Association and American Stroke Association have issued an updated guideline for the diagnosis and treatment of acute ischemic stroke.The new guideline, published in Stroke, ...
Overlooked or underestimated risk factors may warrant more consideration in stroke prevention and epidemiology, according to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results